426 related articles for article (PubMed ID: 11956089)
21. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines.
Taomoto J; Yoshida K; Wada Y; Tanabe K; Konishi K; Tahara H; Fukushima M
Oncology; 2006; 70(6):458-64. PubMed ID: 17237621
[TBL] [Abstract][Full Text] [Related]
23. Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
de Bruin M; van Capel T; Smid K; van der Born K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1485-90. PubMed ID: 15571282
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase.
Kong X; Fan H; Liu X; Wang R; Liang J; Gupta N; Chen Y; Fang F; Chang Y
Mol Pharmacol; 2009 Oct; 76(4):854-60. PubMed ID: 19602572
[TBL] [Abstract][Full Text] [Related]
25. Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.
Pizzorno G; Cao D; Leffert JJ; Russell RL; Zhang D; Handschumacher RE
Biochim Biophys Acta; 2002 Jul; 1587(2-3):133-44. PubMed ID: 12084455
[TBL] [Abstract][Full Text] [Related]
26. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
27. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
Rustum YM; Danhauser L; Luccioni C; Au JL
Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
[TBL] [Abstract][Full Text] [Related]
28. [Mode of action of fluoropyrimidines, in relation to their clinical application].
Suga S; Kimura K; Kubo K; Aoyama H; Inukai N; Kato K; Horiuchi T; Sawada H; Yokoyama Y
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2301-6. PubMed ID: 6497396
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
31. [Development of fluoropyrimidine derivatives].
Fujii S; Shirasaka T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2316-28. PubMed ID: 6238573
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
[TBL] [Abstract][Full Text] [Related]
33. Pyrimidine metabolism in Tritrichomonas foetus.
Jarroll EL; Lindmark DG; Paolella P
J Parasitol; 1983 Oct; 69(5):846-9. PubMed ID: 6200591
[TBL] [Abstract][Full Text] [Related]
34. Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.
Miyashita H; Takebayashi Y; Eliason JF; Fujimori F; Nitta Y; Sato A; Morikawa H; Ohashi A; Motegi K; Fukumoto M; Mori S; Uchida T
Cancer; 2002 Jun; 94(11):2959-66. PubMed ID: 12115385
[TBL] [Abstract][Full Text] [Related]
35. [Purification and characterization of a uridine phosphorylase from Enterobacter aerogenes EAM-Z1].
Ruan Q; Zhou C; Xu X; Wu W
Wei Sheng Wu Xue Bao; 2003 Jun; 43(3):354-60. PubMed ID: 16279202
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel human uridine phosphorylase.
Johansson M
Biochem Biophys Res Commun; 2003 Jul; 307(1):41-6. PubMed ID: 12849978
[TBL] [Abstract][Full Text] [Related]
37. Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro.
Mader RM; Sieder AE; Braun J; Rizovski B; Kalipciyan M; Mueller MW; Jakesz R; Rainer H; Steger GG
Biochem Pharmacol; 1997 Dec; 54(11):1233-42. PubMed ID: 9416974
[TBL] [Abstract][Full Text] [Related]
38. Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase.
Cuq P; Rouquet C; Evrard A; Ciccolini J; Vian L; Cano JP
Br J Cancer; 2001 Jun; 84(12):1677-80. PubMed ID: 11401323
[TBL] [Abstract][Full Text] [Related]
39. 5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens.
Al Safarjalani ON; Zhou XJ; Rais RH; Shi J; Schinazi RF; Naguib FN; El Kouni MH
Cancer Chemother Pharmacol; 2005 Jun; 55(6):541-51. PubMed ID: 15729584
[TBL] [Abstract][Full Text] [Related]
40. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
Au JL; Rustum YM; Minowada J; Srivastava BI
Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]